Speciality: Pediatrics
Description:
A warm welcome to all the medical professionals in this interesting session of growth deficiency and short stature.
In this webinar, the three eminent speakers Dr. Archana Arya, Dr. Nikhil Lohiya and Dr Sirisha Kusuma B have spoken on the factors that contribute to growth and cause defects like short stature in babies.
A lot of concerns are associated regarding growth patterns in babies or adolescents. The webinar is to give you complete insight on the mechanism of growth, which factors or conditions contribute to the event of short stature in babies.
Short stature is a term applied to a child whose height is 2 standard deviations (SD) or more below the mean for children of that sex and chronologic age. It is a type of deficiency in children that hinders the height of the babies. Learn about it in detail with the help of case studies.
Therefore, listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
1.
COVID Lockdowns Significantly Increasing Children's Vitamin D Deficiency?
2.
Adipocytes in the bone marrow offer early indicators of the development of multiple myeloma from MGUS.
3.
The need for more Latinx participants in Alzheimer's trials is urgent.
4.
Prostate cancer therapies: AI-based image analysis detects early organ damage
5.
For MDS-Related Anemia, Telomerase Inhibitor Approved.
1.
Lu-177 Vipivotide in Prostate Cancer: A Breakthrough in Radioligand Therapy
2.
Revolutionizing Oncology: AI in Radiology, Machine Learning in Pathology, and Deep Learning for Cancer Detection
3.
The Danger of Methemoglobinemia and How to Prevent It
4.
Unlocking the Potential of Talquetamab: A Revolutionary Approach to Cancer Treatment
5.
The Predictive Power of Targeted Radionuclide Therapy in Advanced Breast Cancer
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Efficient Management of First line ALK-rearranged NSCLC - Part VII
2.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
3.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion
4.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VI
5.
Evolution in Treatment and Diagnosis of Lung Cancer- An Initiative from Manipal Hospitals
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation